Goldman Sachs lowered the firm’s price target on Axon (AXON) to $720 from $800 and keeps a Buy rating on the shares. Axon outlined a multi-year financial framework, the analyst tells investors in a research note. The company is leveraging growth in AI software, international markets, Corrections, and Enterprise, while embedding AI into its sensor products to strengthen its role as a data and vision platform for public safety and enterprise applications, Goldman argues.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXON:
- Axon price target raised to $950 from $925 at TD Cowen
- Axon price target lowered to $675 from $713 at Morgan Stanley
- Axon price target lowered to $690 from $753 at Piper Sandler
- Axon: Strong Q4 Momentum and Upgraded Long-Term Outlook Underpin Buy Rating
- Axon price target lowered to $682 from $702 at Barclays